InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (28 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
28
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Sandercock Brett, Chief Financial Officer. Director active across 1 company, notably RESMED INC. Cumulatively, 53 disclosures have been recorded. Split: 0 buy · 28 sells. Total volume traded: €13.8m. History available since 10 May 2021. The latest transaction was filed on 1 April 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Sandercock Brett
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations53 total
1,000 shares@ US$224.310.7% of flowResMed Common StockSEC:0000943819-26-000020:0
1,000 shares@ US$254.301.0% of flowResMed Common StockSEC:0000943819-26-000013:0
1,000 shares@ US$257.031.0% of flowResMed Common StockSEC:0000943819-26-000008:0
1,000 shares@ US$241.751.0% of flowResMed Common StockSEC:0000943819-26-000002:0
1,000 shares@ US$244.161.0% of flowResMed Common StockSEC:0000943819-25-000184:0
2,710 shares0ResMed Common StockSEC:0000943819-25-000171:0
2,000 shares@ US$101.640.9% of flowResMed Common StockSEC:0000943819-25-000092:0
2,000 shares@ US$101.640.9% of flowResMed Common StockSEC:0000943819-25-000084:0
2,000 shares@ US$101.640.9% of flowResMed Common StockSEC:0000943819-25-000052:0
5,462 shares0ResMed Common StockSEC:0000943819-25-000040:0
2,000 shares@ US$101.640.9% of flowResMed Common StockSEC:0000943819-25-000032:0
1,966 shares@ US$101.640.9% of flowResMed Common StockSEC:0000943819-25-000025:0
1,000 shares@ US$243.781.1% of flowResMed Common StockSEC:0000943819-25-000011:0
3,644 shares@ US$244.593.6% of flowResMed Common StockSEC:0001127602-25-015607:0
1,000 shares@ US$215.580.7% of flowResMed Common StockSEC:0001127602-25-011925:0
1,000 shares@ US$230.360.8% of flowResMed Common StockSEC:0001127602-25-009188:0
1,000 shares@ US$238.980.9% of flowResMed Common StockSEC:0001127602-25-004042:0
1,000 shares@ US$234.040.9% of flowResMed Common StockSEC:0001127602-25-001067:0
1,000 shares@ US$244.230.9% of flowResMed Common StockSEC:0001127602-24-029095:0
1,000 shares@ US$249.000.9% of flowResMed Common StockSEC:0001127602-24-027030:0
1,000 shares@ US$233.470.8% of flowResMed Common StockSEC:0001127602-24-025369:0
1,000 shares@ US$246.420.8% of flowResMed Common StockSEC:0001127602-24-023758:0
7,915 shares0ResMed Common StockSEC:0001127602-24-022304:0
1,000 shares@ US$212.160.7% of flowResMed Common StockSEC:0001127602-24-021984:0
1,000 shares@ US$194.350.7% of flowResMed Common StockSEC:0001127602-24-020248:0
25 of 53 declarations
About Sandercock Brett
Sandercock Brett is Directeur Financier at RESMED INC (Chief Financial Officer). The declarant has 53 filings in total, and across the 53 sampled filings between 2021-05-11 and 2026-04-03, the transactions are sales for a total of EUR 13,825,595.
